Pharmaceutical manufacturer Cambrex plans High Point expansion
Pharmaceutical manufacturer Cambrex Corp. said Friday it will create 78 new jobs in High Point as part of a $30 million manufacturing expansion.
Cambrex focuses on the small molecule sector that provides drug substance, drug product and analytical services across the entire drug lifecycle.
With 40 years’ experience, Cambrex serves clients in North America and Europe by providing full-service research, development and commercial manufacturing.
The expansion will affect its small batch manufacturing capacity with additional production and laboratory space.